cached image

Barry B. Wolfe - Publications

Affiliations: 
Georgetown University, Washington, DC 
Area:
Nicotinic acetylcholine receptors
Website:
http://www9.georgetown.edu/gumc/departments/pharmacology/faculty/facwolfe.html

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Dalley CB, Wolfe BB, Wroblewski JT. Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9. PMID 26291396 DOI: 10.1016/J.Bcp.2015.08.091  0.397
2015 Tuan EW, Horti AG, Olson TT, Gao Y, Stockmeier CA, Al-Muhtasib N, Bowman Dalley C, Lewin AE, Wolfe BB, Sahibzada N, Xiao Y, Kellar KJ. AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors. Molecular Pharmacology. 88: 640-9. PMID 26162864 DOI: 10.1124/Mol.115.099978  0.436
2015 DiRaddo JO, Miller EJ, Bowman-Dalley C, Wroblewska B, Javidnia M, Grajkowska E, Wolfe BB, Liotta DC, Wroblewski JT. Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors. Molecular Pharmacology. 88: 450-9. PMID 26089372 DOI: 10.1124/Mol.114.096420  0.36
2015 Hathaway HA, Pshenichkin S, Grajkowska E, Gelb T, Emery AC, Wolfe BB, Wroblewski JT. Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208. PMID 25700650 DOI: 10.1016/J.Neuropharm.2015.02.007  0.401
2015 Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20. PMID 25065592 DOI: 10.1038/Onc.2014.231  0.364
2012 Emery AC, DiRaddo JO, Miller E, Hathaway HA, Pshenichkin S, Takoudjou GR, Grajkowska E, Yasuda RP, Wolfe BB, Wroblewski JT. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. Molecular Pharmacology. 82: 291-301. PMID 22584219 DOI: 10.1124/Mol.112.078444  0.387
2011 Hussmann GP, Yasuda RP, Xiao Y, Wolfe BB, Kellar KJ. Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors. The Journal of Biological Chemistry. 286: 39726-37. PMID 21940627 DOI: 10.1074/Jbc.M111.289546  0.369
2011 Lomazzo E, Hussmann GP, Wolfe BB, Yasuda RP, Perry DC, Kellar KJ. Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons. Journal of Neurochemistry. 119: 153-64. PMID 21806615 DOI: 10.1111/J.1471-4159.2011.07408.X  0.301
2011 Xiao Y, Tuan E, Yasuda RP, Sahibzada N, Wolfe BB, Horton L, Tran T, Al-Muhtasib N, Iwueze AF, Dipietro JR, Xie T, Paige M, Brown ML, Kellar KJ. Pharmacological properties of sazetidine A, a selective ligand of α4β2 nicotinic acetylcholine receptors Biochemical Pharmacology. 82: 1029. DOI: 10.1016/J.Bcp.2011.07.019  0.321
2010 Lomazzo E, MacArthur L, Yasuda RP, Wolfe BB, Kellar KJ. Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus. Journal of Neurochemistry. 115: 625-34. PMID 20796176 DOI: 10.1111/J.1471-4159.2010.06967.X  0.388
2010 Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, Wroblewski JT. The protective signaling of metabotropic glutamate receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. The Journal of Biological Chemistry. 285: 26041-8. PMID 20566651 DOI: 10.1074/jbc.M110.139899  0.384
2006 Lu C, Fu Z, Karavanov I, Yasuda RP, Wolfe BB, Buonanno A, Vicini S. NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons. Journal of Neurophysiology. 96: 2282-94. PMID 16885526 DOI: 10.1152/Jn.00078.2006  0.322
2006 Mao D, Yasuda RP, Fan H, Wolfe BB, Kellar KJ. Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia. Molecular Pharmacology. 70: 1693-9. PMID 16882879 DOI: 10.1124/mol.106.027458  0.434
2005 Marritt AM, Cox BC, Yasuda RP, McIntosh JM, Xiao Y, Wolfe BB, Kellar KJ. Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes. Molecular Pharmacology. 68: 1656-68. PMID 16129735 DOI: 10.1124/Mol.105.012369  0.523
2004 Hernandez SC, Vicini S, Xiao Y, Dávila-García MI, Yasuda RP, Wolfe BB, Kellar KJ. The nicotinic receptor in the rat pineal gland is an alpha3beta4 subtype. Molecular Pharmacology. 66: 978-87. PMID 15247319 DOI: 10.1124/Mol.104.002345  0.433
2004 Jarabek BR, Yasuda RP, Wolfe BB. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model. Brain : a Journal of Neurology. 127: 505-16. PMID 14662521 DOI: 10.1093/brain/awh058  0.332
2003 Rissman RA, Mishizen-Eberz AJ, Carter TL, Wolfe BB, De Blas AL, Miralles CP, Ikonomovic MD, Armstrong DM. Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology. Neuroscience. 120: 695-704. PMID 12895510 DOI: 10.1016/S0306-4522(03)00030-7  0.371
2002 Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP. Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Molecular Pharmacology. 62: 1119-27. PMID 12391275 DOI: 10.1124/Mol.62.5.1119  0.322
2002 Brown KM, Wrathall JR, Yasuda RP, Wolfe BB. Quantitative measurement of glutamate receptor subunit protein expression in the postnatal rat spinal cord. Brain Research. Developmental Brain Research. 137: 127-33. PMID 12220704 DOI: 10.1016/S0165-3806(02)00435-2  0.301
2001 Al-Hallaq RA, Yasuda RP, Wolfe BB. Enrichment of N-methyl-D-aspartate NR1 splice variants and synaptic proteins in rat postsynaptic densities. Journal of Neurochemistry. 77: 110-9. PMID 11279267 DOI: 10.1046/j.1471-4159.2001.00210.x  0.32
2000 Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB. Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Brain Research. Molecular Brain Research. 80: 123-31. PMID 11038245 DOI: 10.1016/S0169-328X(00)00111-X  0.309
2000 Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Molecular Pharmacology. 57: 342-52. PMID 10648644  0.363
1999 Dunah AW, Yasuda RP, Luo J, Wang Y, Prybylowski KL, Wolfe BB. Biochemical studies of the structure and function of the N-methyl-D-aspartate subtype of glutamate receptors. Molecular Neurobiology. 19: 151-79. PMID 10371467 DOI: 10.1007/Bf02743658  0.346
1998 Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G, Vicini S. Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. The European Journal of Neuroscience. 10: 1704-15. PMID 9751142 DOI: 10.1046/J.1460-9568.1998.00169.X  0.358
1998 Dunah AW, Luo J, Wang YH, Yasuda RP, Wolfe BB. Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit. Molecular Pharmacology. 53: 429-37. PMID 9495808 DOI: 10.1124/Mol.53.3.429  0.32
1998 Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, Grayson DR. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. Journal of Neurophysiology. 79: 555-66. PMID 9463421 DOI: 10.1152/Jn.1998.79.2.555  0.366
1997 Luo J, Wang Y, Yasuda RP, Dunah AW, Wolfe BB. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Molecular Pharmacology. 51: 79-86. PMID 9016349 DOI: 10.1124/Mol.51.1.79  0.45
1996 Dunah AW, Yasuda RP, Wang YH, Luo J, Dávila-García M, Gbadegesin M, Vicini S, Wolfe BB. Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. Journal of Neurochemistry. 67: 2335-45. PMID 8931465 DOI: 10.1046/J.1471-4159.1996.67062335.X  0.359
1996 Dunah AW, Luo J, Wang YH, Yasuda RP, Wolfe BB. NMDA receptor subunit nr2d identified using a polyclonal antiserum Faseb Journal. 10: A140.  0.361
1996 Luo JH, Wang YH, Yasuda RP, Wolfe BB. The majority of cortical NMDA receptors contain three subunits (NR1/NR2A/NR2B) Faseb Journal. 10: A141.  0.319
1995 Chouinard ML, Gallagher M, Yasuda RP, Wolfe BB, McKinney M. Hippocampal muscarinic receptor function in spatial learning-impaired aged rats. Neurobiology of Aging. 16: 955-63. PMID 8622787 DOI: 10.1016/0197-4580(95)02015-2  0.357
1995 Wolf BA, Wertkin AM, Jolly YC, Yasuda RP, Wolfe BB, Konrad RJ, Manning D, Ravi S, Williamson JR, Lee VM. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells. The Journal of Biological Chemistry. 270: 4916-22. PMID 7876266 DOI: 10.1074/Jbc.270.9.4916  0.375
1995 Emala CW, Aryana A, Levine MA, Yasuda RP, Satkus SA, Wolfe BB, Hirshman CA. Expression of muscarinic receptor subtypes and M2-muscarinic inhibition of adenylyl cyclase in lung. The American Journal of Physiology. 268: L101-7. PMID 7840214  0.313
1995 Wang YH, Bosy TZ, Yasuda RP, Grayson DR, Vicini S, Pizzorusso T, Wolfe BB. Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. Journal of Neurochemistry. 65: 176-83. PMID 7790859 DOI: 10.1046/J.1471-4159.1995.65010176.X  0.439
1995 Wolfe BB, Yasuda RP. Development of selective antisera for muscarinic cholinergic receptor subtypes. Annals of the New York Academy of Sciences. 757: 186-93. PMID 7611674 DOI: 10.1111/j.1749-6632.1995.tb17474.x  0.41
1995 Schachter JB, Wolfe BB. 3-Isobutyl-1-methylxanthine increases alpha-1-adrenergic receptor sensitivity and density in DDT1-MF2 smooth muscle cells. The Journal of Pharmacology and Experimental Therapeutics. 272: 215-23. PMID 7529308  0.342
1994 Wall SJ, Wolfe BB, Kromer LF. Cholinergic deafferentation of dorsal hippocampus by fimbria-fornix lesioning differentially regulates subtypes (m1-m5) of muscarinic receptors. Journal of Neurochemistry. 62: 1345-51. PMID 8133265  0.35
1993 Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, Wolfe BB. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Molecular Pharmacology. 43: 149-57. PMID 8429821  0.333
1993 Rothberg BS, Yasuda RP, Satkus SA, Wolfe BB, Hunter BE. Effects of chronic ethanol on cholinergic actions in rat hippocampus: electrophysiological studies and quantification of m1-m5 muscarinic receptor subtypes. Brain Research. 631: 227-34. PMID 8131051 DOI: 10.1016/0006-8993(93)91539-5  0.331
1993 Wolfe B, Yasuda R, Wall S, Li M, Ciesla W. Development and utilization of a panel of antisera selective for each of the subtypes of muscarinic cholinergic receptor Life Sciences. 52: 584. DOI: 10.1016/0024-3205(93)90385-G  0.404
1992 Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology. 41: 31-7. PMID 1732720  0.504
1992 Wall SJ, Yasuda RP, Li M, Ciesla W, Wolfe BB. The ontogeny of m1-m5 muscarinic receptor subtypes in rat forebrain. Brain Research. Developmental Brain Research. 66: 181-5. PMID 1606683 DOI: 10.1016/0165-3806(92)90078-B  0.334
1992 Schachter JB, Wolfe BB. Cyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell line. Molecular Pharmacology. 41: 587-97. PMID 1312218  0.329
1992 Schachter JB, Ivins JK, Pittman RN, Wolfe BB. Competitive regulation of phospholipase C responses by cAMP and calcium. Molecular Pharmacology. 41: 577-86. PMID 1312217  0.445
1991 Wall SJ, Yasuda RP, Hory F, Flagg S, Martin BM, Ginns EI, Wolfe BB. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain. Molecular Pharmacology. 39: 643-9. PMID 2034236  0.402
1991 Wall SJ, Yasuda RP, Li M, Wolfe BB. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Molecular Pharmacology. 40: 783-9. PMID 1944243  0.33
1991 Li M, Yasuda RP, Wall SJ, Wellstein A, Wolfe BB. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Molecular Pharmacology. 40: 28-35. PMID 1857338  0.385
1990 Frazer A, Maayani S, Wolfe BB. Subtypes of receptors for serotonin. Annual Review of Pharmacology and Toxicology. 30: 307-48. PMID 2188571 DOI: 10.1146/Annurev.Pa.30.040190.001515  0.333
1990 Vos P, Kaufmann D, Hand PJ, Wolfe BB. Beta 2-adrenergic receptors are colocalized and coregulated with "whisker barrels" in rat somatosensory cortex. Proceedings of the National Academy of Sciences of the United States of America. 87: 5114-8. PMID 2164222 DOI: 10.1073/Pnas.87.13.5114  0.627
1990 Lee W, Nicklaus KJ, Manning DR, Wolfe BB. Ontogeny of cortical muscarinic receptor subtypes and muscarinic receptor-mediated responses in rat. The Journal of Pharmacology and Experimental Therapeutics. 252: 482-90. PMID 2156047  0.366
1989 Johnson EW, Wolfe BB, Molinoff PB. Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2297-305. PMID 2568408  0.769
1988 Luthin GR, Harkness J, Artymyshyn RP, Wolfe BB. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Molecular Pharmacology. 34: 327-33. PMID 3419425  0.343
1988 Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. The Journal of Pharmacology and Experimental Therapeutics. 244: 987-93. PMID 2908050  0.617
1987 Vos P, Davenport PA, Artymyshyn RP, Frazer A, Wolfe BB. Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol: an autoradiographic study. The Journal of Pharmacology and Experimental Therapeutics. 242: 707-12. PMID 2886650  0.673
1986 Frazer A, Ordway G, O'Donnell J, Vos P, Wolfe B. Effect of repeated administration of clenbuterol on the regulation of beta-adrenoceptors in the central nervous system of the rat. Ciba Foundation Symposium. 123: 170-90. PMID 3028723  0.657
1986 Hedberg A, Gerber JG, Nies AS, Wolfe BB, Molinoff PB. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. The Journal of Pharmacology and Experimental Therapeutics. 239: 117-23. PMID 3020227  0.748
1986 Gil DW, Wolfe BB. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert. The Journal of Pharmacology and Experimental Therapeutics. 237: 577-82. PMID 3009794  0.333
1986 Contreras ML, Wolfe BB, Molinoff PB. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 239: 136-43. PMID 2876092  0.631
1986 Contreras ML, Wolfe BB, Molinoff PB. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 237: 165-72. PMID 2870175  0.716
1986 Contreras ML, Wolfe BB, Molinoff PB. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 237: 154-64. PMID 2870174  0.64
1985 Luthin GR, Wolfe BB. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. The Journal of Pharmacology and Experimental Therapeutics. 234: 37-44. PMID 3839265  0.343
1985 Gil DW, Wolfe BB. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. The Journal of Pharmacology and Experimental Therapeutics. 232: 608-16. PMID 2579230  0.419
1984 Sills MA, Wolfe BB, Frazer A. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex. Molecular Pharmacology. 26: 10-8. PMID 6749126  0.31
1984 Luthin GR, Wolfe BB. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Molecular Pharmacology. 26: 164-9. PMID 6548291  0.369
1984 Rainbow TC, Parsons B, Wolfe BB. Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proceedings of the National Academy of Sciences of the United States of America. 81: 1585-9. PMID 6324206 DOI: 10.1073/Pnas.81.5.1585  0.688
1984 O'Donnell JM, Wolfe BB, Frazer A. Agonist interactions with beta adrenergic receptors in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 228: 640-7. PMID 6142940  0.489
1983 Wolfe BB, Voelkel NF. Effects of hypoxia on atrial muscarinic cholinergic receptors and cardiac parasympathetic responsiveness. Biochemical Pharmacology. 32: 1999-2002. PMID 6870928 DOI: 10.1016/0006-2952(83)90418-5  0.47
1983 Minneman KP, Wolfe BB, Pittman RN, Molinoff PB. beta-Adrenergic receptor subtypes in rat brain. Advances in Biochemical Psychopharmacology. 36: 73-81. PMID 6305157  0.798
1982 Minneman KP, Wolfe BB, Molinoff PB. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Research. 252: 309-14. PMID 6295545 DOI: 10.1016/0006-8993(82)90398-5  0.816
1982 Molinoff PB, Aarons RD, Nies AS, Gerber JG, Wolfe BB, Goens MB. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. British Journal of Clinical Pharmacology. 13: 365S. PMID 6285945 DOI: 10.1111/j.1365-2125.1982.tb01942.x  0.735
1982 Wolfe BB, Minneman KP, Molinoff PB. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Research. 234: 474-9. PMID 6277437 DOI: 10.1016/0006-8993(82)90890-3  0.821
1981 Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Research. 211: 315-27. PMID 7237126 DOI: 10.1016/0006-8993(81)90704-6  0.61
1981 Minneman KP, Pittman RN, Yeh HH, Woodward DJ, Wolfe BB, Molinoff PB. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Research. 209: 25-34. PMID 6260307 DOI: 10.1016/0006-8993(81)91169-0  0.815
1981 Wolfe BB, Augustyn DH, Majocha RE, Dibner MD, Molinoff PB, Baldessarini RJ, Walton KG. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Research. 207: 174-7. PMID 6258728 DOI: 10.1016/0006-8993(81)90689-2  0.727
1981 Wolfe BB, Harden TK. Guanine nucleotides modulate the affinity of antagonists at beta-adrenergic receptors. Journal of Cyclic Nucleotide Research. 7: 303-12. PMID 6124564  0.613
1981 Molinoff PB, Wolfe BB, Weiland GA. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sciences. 29: 427-43. PMID 6116137 DOI: 10.1016/0024-3205(81)90208-3  0.67
1980 Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, Melchior C, Molinoff PB. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. The Journal of Pharmacology and Experimental Therapeutics. 213: 491-6. PMID 6259318  0.763
1980 Dibner MD, Zahniser NR, Wolfe BB, Rabin RA, Molinoff PB. Brain neurotransmitter receptor systems in mice genetically selected for differences in sensitivity to ethanol. Pharmacology, Biochemistry, and Behavior. 12: 509-13. PMID 6104820 DOI: 10.1016/0091-3057(80)90181-1  0.719
1979 Minneman KP, Dibner MD, Wolfe BB, Molinoff PB. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science (New York, N.Y.). 204: 866-8. PMID 35829 DOI: 10.1126/Science.35829  0.813
1978 Wolfe BB, Harden TK, Sporn JR, Molinoff PB. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. The Journal of Pharmacology and Experimental Therapeutics. 207: 446-57. PMID 213556  0.78
1978 Leichtling BH, Su YF, Wimalasena J, Harden TK, Wolfe BB, Wicks WD. Studies of cAMP metabolism in cultured hepatoma cells: presence of functional adenylate cyclase despite low cAMP content and lack of hormonal responsiveness. Journal of Cellular Physiology. 96: 215-23. PMID 209052 DOI: 10.1002/Jcp.1040960210  0.426
1978 Molinoff PB, Sporn JR, Wolfe BB, Harden TK. Regulation of beta-adrenergic receptors in the cerebral cortex. Advances in Cyclic Nucleotide Research. 9: 465-83. PMID 208390  0.728
1978 Johnson GL, Wolfe BB, Harden TK, Molinoff PB, Perkins JP. Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. The Journal of Biological Chemistry. 253: 1472-80. PMID 203594  0.725
1977 Sporn JR, Wolfe BB, Harden TK, Molinoff PB. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Molecular Pharmacology. 13: 1170-80. PMID 201833  0.494
1977 Harden TK, Wolfe BB, Sporn JR, Poulos BK, Molinoff PB. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. The Journal of Pharmacology and Experimental Therapeutics. 203: 132-43. PMID 198523  0.739
1977 Harden TK, Wolfe BB, Sporn JR, Perkins JP, Molinoff PB. Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Research. 125: 99-108. PMID 192417 DOI: 10.1016/0006-8993(77)90362-6  0.772
1977 Wolfe BB, Harden TK, Molinoff PB. In vitro study of beta-adrenergic receptors. Annual Review of Pharmacology and Toxicology. 17: 575-604. PMID 17362 DOI: 10.1146/Annurev.Pa.17.040177.003043  0.777
1976 Sporn JR, Harden TK, Wolfe BB, Molinoff PB. beta-Adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex. Science (New York, N.Y.). 194: 624-6. PMID 10626 DOI: 10.1126/Science.10626  0.767
1976 Wolfe BB, Harden TK, Molinoff PB. beta-adrenergic receptors in rat liver: effects of adrenalectomy. Proceedings of the National Academy of Sciences of the United States of America. 73: 1343-7. PMID 4798 DOI: 10.1073/Pnas.73.4.1343  0.722
1976 Harden TK, Wolfe BB, Molinoff PB. Binding of iodinated beta adrenergic antagonists to proteins derived from rat heart. Molecular Pharmacology. 12: 1-15. PMID 3724  0.653
Show low-probability matches.